Neurosarkoidose

Peter Brøgger Christensen; Yousef Yavarian; Ida Holm; Ismael Barzinji; Claudia Christina Hilt Kristensen

Neurosarkoidose

Translated title of the contribution: Neurosarcoidosis

Peter Brøgger Christensen, Yousef Yavarian, Ida Holm, Ismael Barzinji, Claudia Christina Hilt Kristensen

Research output: Contribution to journal › Journal article › Research › peer-review

14 Downloads (Pure)

Abstract

Neurosarcoidosis (NS) affects 5-10% of sarcoidosis patients and can involve any part of the nervous system. The prognosis can be serious and relapse is common. The diagnostic work-up is difficult with many differential diagnoses in inflammatory, infective and malignant neurological diseases. There is no specific marker for NS. Recently proposed diagnostic criteria for NS emphasise that biopsy plays an important role. Infliximab appears to be effective when other treatments are inadequate. The review summarises the clinical features, imaging and laboratory findings, treatment and prognosis of NS.

Translated title of the contribution	Neurosarcoidosis
Original language	Danish
Article number	V09210704
Journal	Ugeskrift for laeger
Volume	184
Issue number	17
Pages (from-to)	1604-1607
Number of pages	4
ISSN	0041-5782
Publication status	Published - 5 Sept 2022

Access to Document

Christensen et al. (2022). NeurosarkoidoseFinal published version, 815 KBLicence: CC BY-NC-ND 4.0

https://ugeskriftet.dk/videnskab/neurosarkoidoseLicence: CC BY-NC-ND 4.0

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

@article{389aef46406b47988b6d98ef635ee179,

title = "Neurosarkoidose",

abstract = "Neurosarcoidosis (NS) affects 5-10% of sarcoidosis patients and can involve any part of the nervous system. The prognosis can be serious and relapse is common. The diagnostic work-up is difficult with many differential diagnoses in inflammatory, infective and malignant neurological diseases. There is no specific marker for NS. Recently proposed diagnostic criteria for NS emphasise that biopsy plays an important role. Infliximab appears to be effective when other treatments are inadequate. The review summarises the clinical features, imaging and laboratory findings, treatment and prognosis of NS.",

keywords = "Central Nervous System Diseases/diagnostic imaging, Diagnosis, Differential, Humans, Prognosis, Sarcoidosis/diagnosis",

author = "Christensen, {Peter Br{\o}gger} and Yousef Yavarian and Ida Holm and Ismael Barzinji and Kristensen, {Claudia Christina Hilt}",

year = "2022",

month = sep,

day = "5",

language = "Dansk",

volume = "184",

pages = "1604--1607",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "17",

}

TY - JOUR

T1 - Neurosarkoidose

AU - Christensen, Peter Brøgger

AU - Yavarian, Yousef

AU - Holm, Ida

AU - Barzinji, Ismael

AU - Kristensen, Claudia Christina Hilt

PY - 2022/9/5

Y1 - 2022/9/5

N2 - Neurosarcoidosis (NS) affects 5-10% of sarcoidosis patients and can involve any part of the nervous system. The prognosis can be serious and relapse is common. The diagnostic work-up is difficult with many differential diagnoses in inflammatory, infective and malignant neurological diseases. There is no specific marker for NS. Recently proposed diagnostic criteria for NS emphasise that biopsy plays an important role. Infliximab appears to be effective when other treatments are inadequate. The review summarises the clinical features, imaging and laboratory findings, treatment and prognosis of NS.

AB - Neurosarcoidosis (NS) affects 5-10% of sarcoidosis patients and can involve any part of the nervous system. The prognosis can be serious and relapse is common. The diagnostic work-up is difficult with many differential diagnoses in inflammatory, infective and malignant neurological diseases. There is no specific marker for NS. Recently proposed diagnostic criteria for NS emphasise that biopsy plays an important role. Infliximab appears to be effective when other treatments are inadequate. The review summarises the clinical features, imaging and laboratory findings, treatment and prognosis of NS.

KW - Central Nervous System Diseases/diagnostic imaging

KW - Diagnosis, Differential

KW - Humans

KW - Prognosis

KW - Sarcoidosis/diagnosis

UR - http://www.scopus.com/inward/record.url?scp=85137648761&partnerID=8YFLogxK

M3 - Tidsskriftartikel

C2 - 35179115

SN - 0041-5782

VL - 184

SP - 1604

EP - 1607

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

IS - 17

M1 - V09210704

ER -

Neurosarkoidose

Abstract

Access to Document

AUB Link

Other files and links

Fingerprint

Cite this